Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study

NCT03539172 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue and Bone Tumor
Head and Neck Cancer
Sarcoma

Interventions

DRUG: Apatinib Mesylate

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University